MUSE Cell Therapy in New York: What Patients Should Know
New York is home to some of the most discerning and well-informed patients in the country when it comes to health and longevity science. Patients in the New York area who are researching MUSE cell therapy bring high standards — and deserve providers who meet them. Springs Rejuvenation, under the medical direction of Dr. Charles Pereyra MD, offers authentic Dezawa-method MUSE cell protocols for patients exploring this category of regenerative science in the New York region.
MUSE Cells: A Brief Scientific Overview
MUSE is an acronym for Multilineage-differentiating Stress-Enduring cells. They are a naturally occurring subpopulation within mesenchymal stem cell preparations, identified by the SSEA-3 surface marker. Discovered by Professor Mari Dezawa at Tohoku University in Japan in 2010, MUSE cells are distinct from standard MSCs in several ways documented in research:
- They appear to survive in inflamed or low-oxygen environments that cause MSC attrition.
- Research suggests they may migrate autonomously toward signals released by damaged tissue after IV administration.
- They have demonstrated multilineage differentiation potential — the capacity to develop into cell types across mesoderm, ectoderm, and endoderm lineages — without genetic reprogramming.
- Published research to date has not associated MUSE cells with tumor formation risk, distinguishing them from embryonic and iPSC-based approaches.
Authentic Dezawa-method preparations follow the specific isolation and characterization protocols developed by Professor Dezawa's group, including SSEA-3 marker verification. This distinguishes them from general MSC preparations relabeled as MUSE cells.
Why Provenance Matters for New York Patients
New York patients are sophisticated consumers who understand that the label on a product does not always match its contents. In regenerative medicine, this concern is particularly relevant: the term "MUSE cells" is appearing on preparations and protocols that may not meet the scientific definition established by Professor Dezawa's research.
At Springs Rejuvenation, Dr. Charles Pereyra MD and the clinical team work with authenticated Dezawa-method preparations. Patients can ask about cell sourcing, SSEA-3 verification, and production standards — and receive documented answers.
The Case for Domestic Access
Some New York patients exploring cell-based therapies have researched or considered overseas options. Springs Rejuvenation offers a domestic alternative:
- Physician oversight by Dr. Charles Pereyra MD, a licensed US physician.
- Authentic Dezawa-method cell preparations with verifiable sourcing.
- Formal informed consent and clinical evaluation before any protocol.
- Follow-up care available at US centers.
- No need to navigate international travel, overseas logistics, or post-travel care coordination.
What New York Patients Can Expect
The Springs Rejuvenation protocol begins with a clinical consultation with Dr. Charles Pereyra MD. This consultation covers your health history, your specific goals, an honest explanation of what the MUSE cell research supports and what it does not, and answers to your questions. No protocol is recommended without this evaluation.
If MUSE cell therapy is appropriate for your profile, the protocol is designed individually. Administration is typically intravenous, consistent with the autonomous homing mechanism described in research. Monitoring and follow-up are included.
Because this is an experimental therapy, there are no guaranteed outcomes. Results may vary across patients based on many individual factors. Springs Rejuvenation's commitment is to provide access to authentic science, honest information, and physician-supervised care — not promises.
Frequently Asked Questions
**Can I get MUSE cell therapy without traveling to Florida?** Contact the Springs Rejuvenation team to discuss access options for New York-area patients, including consultation and protocol availability.
**How does Springs Rejuvenation verify the authenticity of its MUSE cell preparations?** We work with preparations produced using Dezawa-validated protocols, including SSEA-3 marker verification. Dr. Pereyra can discuss cell characterization documentation during your consultation.
**Is this covered by insurance?** No. MUSE cell therapy is experimental and not covered by health insurance. Springs Rejuvenation can discuss financing options during your consultation.
**What makes Dr. Pereyra qualified to offer this protocol?** Dr. Charles Pereyra MD is the medical director of Springs Rejuvenation and has built his regenerative practice on authentic Dezawa-method science. He is a licensed US physician and will provide full informed consent and clinical evaluation before any enrollment. Results may vary.
Our Stem Cell exosome formula is produced in an FDA approved lab, but is not an FDA approved therapy. It is currently in the experimental stages — all information provided is based on our experience with patients. Results may vary.